Chargement en cours...
X-Aptamer Technology Identifies C4A and ApoB in Blood as Potential Markers for Schizophrenia
The field of proteomics is rapidly gaining territory as a promising alternative to genomic approaches in the efforts to unravel the complex molecular mechanisms underlying schizophrenia and other psychiatric disorders. X-aptamer technology has emerged as a novel proteomic approach for high-sensitiv...
Enregistré dans:
| Publié dans: | Mol Neuropsychiatry |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger AG
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6465722/ https://ncbi.nlm.nih.gov/pubmed/31019918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000492331 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|